// App-Quantinova.ai

237 : Cognitive dysfunction in systemic lupus erythematosus: is there a contribution from cardiovascular risk factors?

Researchers

Presenter

  • Michelle Barraclough

Principal Investigators

  • Rebecca Elliott

  • Shane McKie

  • Alan Jackson

  • Phil Pemberton

  • Ian N Bruce

  • Ben Parker

Medical Centers

  • Arthritis Research UK Centre for Epidemiology, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UNITED KINGDOM

  • NIHR Manchester Biomedical Research Centre, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UNITED KINGDOM

  • Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UNITED KINGDOM

  • FBMH Platform Sciences, Enabling Technologies & Infrastructure, The University of Manchester, Manchester, United Kingdom

  • Wolfson Molecular Imaging Centre, Institute of imaging and bioinformatics, The University of Manchester, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

  • Cognitive dysfunction

  • Neuropsychiatric systemic lupus erythematosus

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Sanofi

Result

  • N/A